Researchers Correct Cancer Study Mistake, Shedding New Light on Metabolism

Researchers at the University of Michigan School of Medicine have corrected a mistake in a previously published study on cancer metabolism. The correction, which was made to a study published in the journal Nature on September 2, 2020, involves a figure that was mistakenly duplicated in the original article. According to the correction, the mistake occurred in Extended Data Fig. 1j, where a representative flow cytometry dot plot for the condition SupSer was mistakenly duplicated from a plot for the condition A375 sup. The corrected figure has been updated in both the HTML and PDF versions of the article. The original study, which was conducted by a team of researchers led by Yingjie Bian and Wei Li, explored the relationship between cancer metabolism and tumour immunology. The study found that the SLC43A2 gene, which is involved in cancer metabolism, alters T cell methionine metabolism and histone methylation. In a statement, the researchers acknowledged the mistake and expressed gratitude for the opportunity to correct it. "We appreciate the diligence of the reviewers and the editors in bringing this to our attention," said Bian and Li in a joint statement. "We are confident that the corrected figure will not affect the overall conclusions of our study." The study's findings have significant implications for our understanding of cancer metabolism and tumour immunology. Cancer metabolism refers to the unique metabolic processes that occur in cancer cells, which can be exploited by researchers to develop new treatments. Tumour immunology, on the other hand, involves the study of the immune system's response to cancer. The University of Michigan School of Medicine is a leading institution in the field of cancer research, and the study's findings are a testament to the institution's commitment to advancing our understanding of cancer. The researchers' work has the potential to lead to new treatments and therapies for cancer patients. The corrected study is now available online, and the researchers are continuing to explore the implications of their findings. The study's lead authors, Bian and Li, are currently working on further research to confirm their results and explore new avenues for cancer treatment.